Rajahmundry, Andhra Pradesh: GlaxoSmithKline Asia Private Limited, the makers of Sensodyne, in association with Sevamob (NGO) launched primary healthcare mobile van in Rajahmundry, Andhra Pradesh today. This program was launched by GlaxoSmithKline Asia Private Limited representatives and Sevamob’s team.
The objective of the program is to increase the access of primary healthcare services to the communities at grassroot level. GlaxoSmithKline Asia Private Limited, makers of Sensodyne, will be financially supporting the camps under its CSR initiative.
Under this program,Sevamob will conduct 20+ free primary healthcare camps per month across the district. Each camp will provide access to healthcare services to 70+ patients per day and about 19000+ patients over the next one year.
These camps will be run by registered MBBS Doctors, and trained nurses. Doctors will conduct health check-ups on patients. The mobile van will provide free medicines along with eye-glasses, if required, as per the doctor’s prescription to the patients visiting the camp.
Speaking on partnering, Shanu Saksena, Head CSR, GlaxoSmithKline Asia Private Limited said, “We believe that every citizen must have the right to quality healthcare. As a healthcare company, we have always believed in giving back to society and we hope that this initiative addresses the healthcare challenges faced by many people. We are thankful to our partners and team of experts that have made our vision come alive through their hard work and dedication in the field of healthcare.”
Shelley Saxena, Founder and CEO,Sevamob Ventures Ltd., said “The objective of the program is to increase access to healthcare for communities. We have partnered with GlaxoSmithKline Asia Private Limited, to provide free healthcare services to communities. Through this program, we aim to bridge the gaps in healthcare services delivery and provide quality services at the grassroot to ensure healthcare for all.”
The aim of this CSR partnership is to bring positive change in the society and deliver quality healthcare services for all.
Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content.
